Second Line Capital’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$3.58M	Buy	385,467 +39,369	+11%	+$365K	0.83%	27
2025 Q1	$2.54M	Buy	346,098 +6,000	+2%	+$44K	0.65%	34
2024 Q4	$2.9M	Buy	340,098 +77,288	+29%	+$660K	0.78%	32
2024 Q3	$2.29M	Hold	262,810	–	–	0.62%	39
2024 Q2	$1.8M	Buy	+262,810	New	+$1.8M	0.55%	40